Top 10 stocks for today

1 Jul 2022 , 08:08 AM

Here are the top 10 stocks for today which have major news in them and the potential to move to markets:

1. The Phoenix Mills:

GIC Real Estate further invests Rs400 crore in The Phoenix Mills Ltd. subsidiaries (PML). An additional share subscription agreement has been signed by GIC’s Reco Zinnia Pvt Ltd (RZPL) and each of PML’s subsidiaries (Offbeat Developers or ODPL, Graceworks Realty and Leisure or GRLPL, and Vamona Developers or VDPL). With this, RZPL has finished its second round of private placement investments totalling Rs400 crore in ODPL, VDPL, and GRLPL. As a result, PML and RZPL each own an interest in the PML subsidiaries equal to 67.10% and 32.90%.

1. Hindustan Unilever Ltd:

Sanjiv Mehta, the president commissioner of HUL, will lead Unilever Indonesia. Sanjiv Mehta, the CEO and managing director of HUL was announced as the president commissioner (non-executive chairman) of PT Unilever Indonesia Tbk (Unilever Indonesia), a publicly-traded company and affiliate of Unilever group, in HUL’s BSE filing. He will continue to serve as president of Unilever South Asia as well as CEO and managing director of HUL.

1. Globus Spirits:

Globus Spirits Ltd will offer a range of services to Tilaknagar Industries’ distillery assets. For Tilaknagar Industries’ distillery assets, GSL will offer a range of services, including engineering, operations, maintenance, and marketing. In Maharashtra’s Ahmednagar, it will run a facility. As a portion of the core profit produced by the assets of the distillery, the company will get service fees.

1. UPL:

Nature Bliss Agro Ltd., a crop protection company, is purchased by UPL (NBAL). The business has bought a 100% stake in NBAL, which plans to manufacture and sell crop protection products and related goods that complement UPL’s current commercial operations.

1. Lupin:

Paliperidone tablets used to treat schizophrenia have been approved by the US FDA for Lupin. Paliperidone extended-release tablets from the pharmaceutical company’s Abbreviated New Drug Application (ANDA) have been approved by the US FDA. The medication is a generic version of Janssen Research & Development, LLC’s Invega extended-release tablets. The item will be produced at Lupin’s Goa factory. According to IQVIA MAT data from March 2022, the drug’s US yearly sales were anticipated to be $152 million. The medication is used to treat the mental illness schizophrenia.

1. Blue Star:

Blue Star’s credit facilities and NCDs now have a stable outlook from CARE. The outlook was changed from “Negative” to “Stable” based on the healthy recovery and demand for air-conditioning and refrigeration products following the ebbing of the second wave of the pandemic and the ensuing improvement in operating and financial performance for FY22. CARE has reaffirmed its long- and short-term ratings on credit facilities and non-convertible debentures at AA+.

1. Bharti Airtel:

The telecom provider stated that it has chosen to postpone by up to four years the payment of AGR obligations up to FY 2018—19 that are not listed in the Supreme Court’s judgment. It would not exercise the option to convert the accruing interest dues into equity and has kept the right to prepay installment amounts.

1. Maruti Suzuki, Hero MotoCorp & Auto stocks:

The automakers will disclose how many vehicles–two-wheelers as well as four-wheelers–were sold in June 2022. On the first day of every new month, auto businesses are required to release the monthly sales figures for the preceding month.

1. Hindustan Copper:

The state-owned metal company said that its board has recommended asking shareholders for permission to issue debentures for up to Rs 500 crore. The board has also suggested requesting the shareholders’ consent at the upcoming annual general meeting in order to raise money through the issuance of equity shares through QIP.

1. Kalyan Jewellers:

The jeweller announced the launch of three new stores, two in Maharashtra and one in Delhi, as a part of the business’s aim to refocus on entering tier II and III markets while continuing to increase its footprint in major cities.